Cargando…

Higher serum phosphorus is associated with catabolic/anabolic imbalance in heart failure

BACKGROUND: A higher serum phosphate level is associated with worse outcome. Energy-demanding intracellular transport of phosphate is needed to secure anion bioavailability. In heart failure (HF), energy starvation may modify intracellular and serum levels of phosphate. We analysed determinants of s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rozentryt, Piotr, Niedziela, Jacek T, Hudzik, Bartosz, Lekston, Andrzej, Doehner, Wolfram, Jankowska, Ewa A, Nowak, Jolanta, von Haehling, Stephan, Partyka, Robert, Rywik, Tomasz, Anker, Stefan D, Ponikowski, Piotr, Poloński, Lech
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670741/ https://www.ncbi.nlm.nih.gov/pubmed/26672973 http://dx.doi.org/10.1002/jcsm.12026

Ejemplares similares

The obesity paradox in acute coronary syndrome: a meta-analysis
por: Niedziela, Jacek, et al.
Publicado: (2014)

Weight loss in heart failure is associated with increased mortality only in non‐obese patients without diabetes
por: Niedziela, Jacek T., et al.
Publicado: (2019)

Higher Serum Phosphorus Is Not an Independent Risk Factor of Mortality in Heart Failure with Reduced Ejection Fraction
por: Robert, Partyka, et al.
Publicado: (2021)

The Association between Serum Levels of 25[OH]D, Body Weight Changes and Body Composition Indices in Patients with Heart Failure
por: Stefaniak, Apolonia, et al.
Publicado: (2020)

The effects of a high-caloric protein-rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers: a randomized, double-blind pilot study
por: Rozentryt, Piotr, et al.
Publicado: (2010)

The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats
por: Pötsch, Mareike S., et al.
Publicado: (2013)

CHA(2)DS(2)-VASc score is useful in predicting poor 12-month outcomes following myocardial infarction in diabetic patients without atrial fibrillation
por: Hudzik, Bartosz, et al.
Publicado: (2016)

Iron status, catabolic/anabolic balance, and skeletal muscle performance in men with heart failure with reduced ejection fraction
por: Tkaczyszyn, Michał, et al.
Publicado: (2021)

Five-year survival of patients with chronic systolic heart failure of ischemic and non-ischemic etiology: analysis of prognostic factors
por: Mościński, Mateusz, et al.
Publicado: (2014)

Testing for antiphospholipid antibodies at autopsy
por: Hudzik, Bartosz, et al.
Publicado: (2014)

Lancisi sign: giant C-V waves of tricuspid regurgitation
por: Hudzik, Bartosz, et al.
Publicado: (2016)

Identification of Chronic Heart Failure Patients with a High 12-Month Mortality Risk Using Biomarkers Including Plasma C-Terminal Pro-Endothelin-1
por: Jankowska, Ewa A., et al.
Publicado: (2011)

Clinical and laboratory determinants of low serum level of 25-hydroxyvitamin D during escalation of pharmacotherapy in heart failure patients
por: Myrda, Krzysztof, et al.
Publicado: (2015)

Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)
por: von Haehling, Stephan, et al.
Publicado: (2010)

Skeletal myopathy in patients with chronic heart failure: significance of anabolic-androgenic hormones
por: Josiak, Krystian, et al.
Publicado: (2014)

Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives
por: Jankowska, Ewa A., et al.
Publicado: (2013)

The Use of Anabolic Agents in Catabolic States
por: Demling, Robert
Publicado: (2007)

Sodium-Glucose Cotransporter-2 Inhibitors-from the Treatment of Diabetes to Therapy of Chronic Heart Failure
por: Kurczyński, Dominik, et al.
Publicado: (2022)

Epigenetic Regulation of Chondrocyte Catabolism and Anabolism in Osteoarthritis
por: Kim, Hyeonkyeong, et al.
Publicado: (2015)

Vibration paradox in orthodontics: Anabolic and catabolic effects
por: Alikhani, Mani, et al.
Publicado: (2018)

Coupled catabolism and anabolism in autocatalytic RNA sets
por: Arsène, Simon, et al.
Publicado: (2018)

The Impact of Short-Term Outdoor Air Pollution on Clinical Status and Prognosis of Hospitalized Patients with Coronary Artery Disease Treated with Percutaneous Coronary Intervention
por: Desperak, Piotr, et al.
Publicado: (2022)

Iron Deficiency and Reduced Muscle Strength in Patients with Acute and Chronic Ischemic Stroke
por: Scherbakov, Nadja, et al.
Publicado: (2022)

The obesity paradox in chronic disease: facts and numbers
por: Lainscak, Mitja, et al.
Publicado: (2012)

The Role of Anabolic Hormones for Wound Healing in Catabolic States
por: Demling, Robert H.
Publicado: (2005)

Skeletal muscle weakness is related to insulin resistance in patients with chronic heart failure
por: Doehner, Wolfram, et al.
Publicado: (2015)

Iron deficiency as energetic insult to skeletal muscle in chronic diseases
por: Dziegala, Magdalena, et al.
Publicado: (2018)

Patients with heart failure and concomitant chronic obstructive pulmonary disease participating in the Heart Failure Pilot Survey (ESC-HF Pilot) – Polish population
por: Straburzyńska-Migaj, Ewa, et al.
Publicado: (2015)

Single nucleotide polymorphisms for genes encoding cytokines in the context of cardiac surgery. Part I: Heart transplantation
por: Danikiewicz, Aleksander, et al.
Publicado: (2015)

Airway microbiota signals anabolic and catabolic remodeling in the transplanted lung
por: Mouraux, Stéphane, et al.
Publicado: (2018)

P2Y Receptors in Bone - Anabolic, Catabolic, or Both?
por: Zhou, Yuhan, et al.
Publicado: (2022)

Highlights from the 7th Cachexia Conference: muscle wasting pathophysiological detection and novel treatment strategies
por: Ebner, Nicole, et al.
Publicado: (2014)

Comparison of outcomes in patients undergoing rotational atherectomy after unsuccessful coronary angioplasty versus elective rotational atherectomy
por: Gorol, Jaroslaw, et al.
Publicado: (2018)

The Relationship between VEGFA and TGFB1 Polymorphisms and Target Lesion Revascularization after Elective Percutaneous Coronary Intervention
por: Osadnik, Tadeusz, et al.
Publicado: (2017)

Recent developments in the treatment of cachexia: highlights from the 6th Cachexia Conference
por: Ebner, Nicole, et al.
Publicado: (2012)

Anabolic and catabolic responses of human articular chondrocytes to varying oxygen percentages
por: Ströbel, Simon, et al.
Publicado: (2010)

RNA binding proteins regulate anabolic and catabolic gene expression in chondrocytes
por: McDermott, B.T., et al.
Publicado: (2016)

Pharmacological inhibition of tumor anabolism and host catabolism as a cancer therapy
por: Schcolnik-Cabrera, Alejandro, et al.
Publicado: (2021)

Who is eligible for randomized trials? A comparison between the exclusion criteria defined by the ISCHEMIA trial and 3102 real-world patients with stable coronary artery disease undergoing stent implantation in a single cardiology center
por: Wasilewski, Jarosław, et al.
Publicado: (2015)

IGF-1 treatment reduces weight loss and improves outcome in a rat model of cancer cachexia
por: Schmidt, Katja, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_irer3b0cucn8fa1mlv5362kbij